Trametinib, a mitogen-activated protein kinase inhibitor, may reduce morbidity & mortality in children w/ severe #cvHCM caused by pathogenic variants in the RAS/ mitogen-activated protein kinase signaling pathway.
Read more: https://t.co/4S8jG66f9n #JACCBTS#cvSurg
Syndrome de #Noonan: un médicament contre le cancer jugé prometteur pour prévenir l’apparition de graves problèmes cardiaques chez les enfants atteints de cette maladie génétique rare. @GregAndelfinger
https://t.co/qu1aM07KWW
Hot off the press! Excited to share our work ‘Impact of MEK Inhibition on
Childhood RASopathy-Associated
Hypertrophic Cardiomyopathy’ published in JACC BTS! Huge shoutout to all co-authors who stuck with us!! https://t.co/kIMHRF78gJ
The Ghersi Lab is hiring! We're seeking passionate PhD students and postdocs to join our team at the brand-new Sainte-Justine Research Center. If you're excited about studying blood stem cell formation using zebrafish development, apply now! More info at https://t.co/lcGuNJAbru🩸
Check out the first release of our @nf_core@nextflowio pipeline for processing @ResolveBioSci Molecular Cartography data🤩! Had a lot of fun working on this with @KresBestak 🎉. Reach out to us if you have any questions or need help getting started!
Join us for the 2024 Weinstein Cardiovascular Development and Regeneration Conference in Montreal, May 15-17! Registration and abstract submission are now open at https://t.co/UhMpdvdmhW
Please share, retweet and distribute! #WeinsteinCVD2024
Great pleasure to visit @rmarinjuez group and share our research @ChuSteJustine! Get so many interesting questions and discussion with people from the amazing group! 😃
How to criss cross a heart: a how to in this awesome story from Sigolène Meilhac's lab!!!
Torsion of the heart tube by shortage of progenitor cells : identification of Greb1l as a genetic determinant of criss-cross heart in mice https://t.co/VJ0z1kEjF8